earnings
confidence high
sentiment negative
materiality 0.80
USANA Q2 net sales $264M (-21% YoY), EPS $1.00 (-47%); FY2022 outlook reiterated
USANA HEALTH SCIENCES INC
2022-Q2 EPS reported
$2.15
revenue$537,341,000
- Net sales $264M (-21% YoY, -18% constant currency); diluted EPS $1.00 vs $1.87 prior year.
- Active customers 559K (-14% YoY); Greater China active customers 278K (-8% YoY, +9% sequentially).
- FY2022 guidance maintained: net sales $1.015B-$1.065B, diluted EPS $3.85-$4.45.
- No share repurchases during quarter; cash $230M; $83M remaining under buyback authorization.
- COVID disruptions in mainland China and other key markets drove underperformance; inflationary pressures noted.